J. Derek Lewis & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.3M Sell
1,123
-14
-1% -$16.5K 0.23% 53
2026
Q2
$1.36M Buy
1,137
+19
+2% +$19.4K 0.26% 49
2026
Q1
$1.03M Buy
1,118
+6
+0.5% +$6.08K 0.23% 59
2025
Q4
$1.2M Buy
+1,112
New +$1.06M 0.28% 48

Other funds holding LLY

J. Derek Lewis & Associates's LLY Position: Q3 2026 in Review

J. Derek Lewis & Associates reduced its Eli Lilly (LLY) stake by 1.2% in Q3 2026, selling an estimated $16.5K and leaving 1,123 shares worth $1.3M. The position accounts for 0.23% of the portfolio, ranked #53.

J. Derek Lewis & Associates first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.36M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • J. Derek Lewis & Associates held 1,123 shares of Eli Lilly worth $1.3M as of Q3 2026.
  • J. Derek Lewis & Associates sold 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
  • Eli Lilly made up 0.23% of J. Derek Lewis & Associates's portfolio in Q3 2026, its #53 holding.
  • J. Derek Lewis & Associates first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • J. Derek Lewis & Associates's Eli Lilly position peaked at $1.36M in Q2 2026.
  • 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on J. Derek Lewis & Associates's 13F filing for Q3 2026, filed 3 Nov 2026.